336 related articles for article (PubMed ID: 16638736)
1. CYP2D6 genotype and phenotype in Amerindians of Tepehuano origin and Mestizos of Durango, Mexico.
Sosa-Macías M; Elizondo G; Flores-Pérez C; Flores-Pérez J; Bradley-Alvarez F; Alanis-Bañuelos RE; Lares-Asseff I
J Clin Pharmacol; 2006 May; 46(5):527-36. PubMed ID: 16638736
[TBL] [Abstract][Full Text] [Related]
2. Influence of CYP2D6 deletion, multiplication, -1584C-->G, 31G-->A and 2988G-->a gene polymorphisms on dextromethorphan metabolism among Mexican tepehuanos and mestizos.
Sosa-Macías M; Dorado P; Alanis-Bañuelos RE; Llerena A; Lares-Asseff I
Pharmacology; 2010; 86(1):30-6. PubMed ID: 20588073
[TBL] [Abstract][Full Text] [Related]
3. Phenotypical expression of CYP2D6 in amerindians of tepehuano origin from Durango, Mexico.
Lares-Asseff I; Sosa-Macías M; Elizondo-Azuela G; Flores-Pérez C; Flores-Pérez J; Bradley-Alvarez F
Proc West Pharmacol Soc; 2005; 48():102-7. PubMed ID: 16416672
[TBL] [Abstract][Full Text] [Related]
4. CYP2D6 gene polymorphisms and predicted phenotypes in eight indigenous groups from northwestern Mexico.
Lazalde-Ramos BP; Martínez-Fierro Mde L; Galaviz-Hernández C; Garza-Veloz I; Naranjo ME; Sosa-Macías M; Llerena A
Pharmacogenomics; 2014 Feb; 15(3):339-48. PubMed ID: 24533713
[TBL] [Abstract][Full Text] [Related]
5. The effect of CYP2D6 polymorphisms on dextromethorphan metabolism in Mexican Americans.
Casner PR
J Clin Pharmacol; 2005 Nov; 45(11):1230-5. PubMed ID: 16239355
[TBL] [Abstract][Full Text] [Related]
6. Cytochrome P4501A1 polymorphisms in the Amerindian and Mestizo populations of Mexico.
Fragoso JM; Juárez-Cedillo T; Hernández-Pacheco G; Ramírez E; Zuñiga J; Izaguirre R; de la Peña A; Granados J; Vargas-Alarcón G
Cell Biochem Funct; 2005; 23(3):189-93. PubMed ID: 15376230
[TBL] [Abstract][Full Text] [Related]
7. Distribution of CYP2D6 and CYP2C19 polymorphisms associated with poor metabolizer phenotype in five Amerindian groups and western Mestizos from Mexico.
Salazar-Flores J; Torres-Reyes LA; Martínez-Cortés G; Rubi-Castellanos R; Sosa-Macías M; Muñoz-Valle JF; González-González C; Ramírez A; Román R; Méndez JL; Barrera A; Torres A; Medina R; Rangel-Villalobos H
Genet Test Mol Biomarkers; 2012 Sep; 16(9):1098-104. PubMed ID: 22913530
[TBL] [Abstract][Full Text] [Related]
8. Concordance of P450 2D6 (debrisoquine hydroxylase) phenotype and genotype: inability of dextromethorphan metabolic ratio to discriminate reliably heterozygous and homozygous extensive metabolizers.
Evans WE; Relling MV
Pharmacogenetics; 1991 Dec; 1(3):143-8. PubMed ID: 1688245
[TBL] [Abstract][Full Text] [Related]
9. CYP2D6 genotype and phenotype determination in a Mexican Mestizo population.
López M; Guerrero J; Jung-Cook H; Alonso ME
Eur J Clin Pharmacol; 2005 Nov; 61(10):749-54. PubMed ID: 16249913
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the CYP2D6 gene mutations and their consequences for enzyme function in a West African population.
Griese EU; Asante-Poku S; Ofori-Adjei D; Mikus G; Eichelbaum M
Pharmacogenetics; 1999 Dec; 9(6):715-23. PubMed ID: 10634134
[TBL] [Abstract][Full Text] [Related]
11. Prediction of phenotype for dextromethorphan O-demethylation by using polymerase chain reaction in healthy volunteers.
Zimmermann T; Schlenk R; Pfaff G; Lach P; Wildfeuer A
Arzneimittelforschung; 1995 Jan; 45(1):41-3. PubMed ID: 7893267
[TBL] [Abstract][Full Text] [Related]
12. CYP2D6 genetic polymorphisms in Southern Mexican Mayan Lacandones and Mestizos from Chiapas.
López-López M; Peñas-Lledó E; Dorado P; Ortega A; Corona T; Ochoa A; Yescas P; Alonso E; LLerena A
Pharmacogenomics; 2014; 15(15):1859-65. PubMed ID: 25495408
[TBL] [Abstract][Full Text] [Related]
13. [Correlation of genetic polymorphism of cytochrome P4502D6 with dextromethorphan oxidative metabolism in Chinese].
Cai W; Chen B; Tao X; Ling S; Zhang Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Jun; 17(3):181-4. PubMed ID: 10837520
[TBL] [Abstract][Full Text] [Related]
14. The AmpliChip CYP450 test: cytochrome P450 2D6 genotype assessment and phenotype prediction.
Rebsamen MC; Desmeules J; Daali Y; Chiappe A; Diemand A; Rey C; Chabert J; Dayer P; Hochstrasser D; Rossier MF
Pharmacogenomics J; 2009 Feb; 9(1):34-41. PubMed ID: 18591960
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphism of CYP2D6 in the Japanese population.
Chida M; Yokoi T; Kosaka Y; Chiba K; Nakamura H; Ishizaki T; Yokota J; Kinoshita M; Sato K; Inaba M; Aoki Y; Gonzalez FJ; Kamataki T
Pharmacogenetics; 1999 Oct; 9(5):601-5. PubMed ID: 10591540
[TBL] [Abstract][Full Text] [Related]
16. Comparative evolutionary pharmacogenetics of CYP2D6 in Ngawbe and Embera Amerindians of Panama and Colombia: role of selection versus drift in world populations.
Jorge LF; Eichelbaum M; Griese EU; Inaba T; Arias TD
Pharmacogenetics; 1999 Apr; 9(2):217-28. PubMed ID: 10376769
[TBL] [Abstract][Full Text] [Related]
17. CYP2D6 genotype and dextromethorphan hydroxylation phenotype in an Ecuadorian population.
Dorado P; Heras N; Machín E; Hernández F; Teran E; Llerena A
Eur J Clin Pharmacol; 2012 May; 68(5):637-44. PubMed ID: 22083166
[TBL] [Abstract][Full Text] [Related]
18. Allele and genotype frequencies of metabolic genes in Native Americans from Argentina and Paraguay.
Bailliet G; Santos MR; Alfaro EL; Dipierri JE; Demarchi DA; Carnese FR; Bianchi NO
Mutat Res; 2007 Mar; 627(2):171-7. PubMed ID: 17194620
[TBL] [Abstract][Full Text] [Related]
19. LMP2 and LMP7 gene polymorphism in Mexican populations: Mestizos and Amerindians.
Vargas-Alarcón G; Gamboa R; Vergara Y; Rodriguez-Zepeda JM; de la Peña A; Izaguirre R; Zuñiga J; Ruiz-Morales JA; Granados J
Genes Immun; 2002 Sep; 3(6):373-7. PubMed ID: 12209365
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous genotyping of CYP2D6*3, *4, *5 and *6 polymorphisms in a Spanish population through multiplex long polymerase chain reaction and minisequencing multiplex single base extension analysis.
Crescenti A; Mas S; Gassó P; Baiget M; Bernardo M; Lafuente A
Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):992-7. PubMed ID: 17714084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
